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In this study Next-Generation Sequencing (NGS) was used to analyze and compare
human microbiota from three different compartments, i.e., saliva, feces, and cancer
tissue (CT), of a selected cohort of 10 Italian patients with colorectal cancer (CRC)
vs. 10 healthy controls (saliva and feces). Furthermore, the Fusobacterium nucleatum
abundance in the same body site was investigated through real-time quantitative
polymerase chain reaction (qPCR) to assess the association with CRC. Differences in
bacterial composition, F. nucleatum abundance in healthy controls vs. CRC patients,
and the association of F. nucleatum with clinical parameters were observed. Taxonomic
analysis based on 16S rRNA gene, revealed the presence of three main bacterial
phyla, which includes about 80% of reads: Firmicutes (39.18%), Bacteroidetes (30.36%),
and Proteobacteria (10.65%). The results highlighted the presence of different bacterial
compositions; in particular, the fecal samples of CRC patients seemed to be enriched
with Bacteroidetes, whereas in the fecal samples of healthy controls Firmicutes were one
of the major phyla detected though these differences were not statistically significant.
The CT samples showed the highest alpha diversity values. These results emphasize
a different taxonomic composition of feces from CRC compared to healthy controls.
Despite the low number of samples included in the study, these results suggest the
importance of microbiota in the CRC progression and could pave the way to the
development of therapeutic interventions and novel microbial-related diagnostic tools
in CRC patients.
Keywords: colorectal cancer, gut microbiota, oral microbiota, Fusobacterium nucleatum, quantitative polymerase
chain reaction, taxonomic analysis
Abbreviations:NGS, Next-Generation Sequencing; CT, cancer tissue; CRC, colorectal cancer; qPCR, Quantitative polymerase
chain reaction; OTUs, operational taxonomic units.
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INTRODUCTION
Colorectal cancer (CRC) is the third most frequent tumor
worldwide and is considered as the fourth leading cause of
cancer deaths (Rowland, 2009), accounting for about 1.2 million
new cases and 600,000 deaths per year. The CRC etiology is
still not fully understood, but the development of colorectal
carcinogenesis is a heterogeneous progression with different
sets of genetic and epigenetic variations, and is influenced by
dietary patterns, environmental conditions, host immunity, and
microbial adhesion (as reviewed in Russo et al., 2016). A large
number of microbes is able to live and thrive in the human gut,
forming huge and complex communities, which, in turn, may
play key roles in the CRC development (Warren et al., 2013; Gao
et al., 2017).
Also, the association between some bacteria with the initiation
and progression of neoplasia, e.g., Helicobacter pylori to gastric
cancer (Amedei et al., 2014), has been well-established. This
infection is the cause of approximately 5.5% of all cancers
(Parkin, 2006). Whilst the fine processes of cancerogenesis have
not been fully elucidated, it is reasonable to prevent its risk by
targeting the possible microbial etiologic agent(s), as previous
studies have suggested a potential dysbiosis of gut microbiota in
CRC patients (Akin and Tözün, 2014).Many works have detected
the hypothetical pathogens linked to CRC pathogenesis, aimed to
improve CRC prevention and treatment (as reviewed in Russo
et al., 2016). In the last years, the 16S rRNA gene sequencing
approach has been widely used as an effective tool to analyze
the complex microbial community (Eckburg et al., 2005). The
obtained results suggested that the breakdown of the intestinal
microbiota structure could promote carcinogenesis and CRC
development.
Other studies of CRCs reported the presence of links between
the intestinal microbiota and bacterial metabolites and the tumor
development in murine colitis-associated CRC models (Gao
et al., 2015; O’Keefe, 2016). Indeed, fermenting bacteria may
produce protective molecules in the colon such as butyrate,
the conjugate base of butyric acid, which has been shown to
exert a beneficial effect on colon cells (Lupton, 2004; Pessione,
2012). On the other hand, the antibiotic suppression of intestinal
microbiota has been shown to reduce the lipoperoxidation
associated with the proliferation of colon carcinogenesis in
murine models (Martin et al., 2015).
The presence of specific microorganisms in the microbiota
and the subsequent inflammation (often microbial driven) and
cancer are linked (Mantovani, 2009; Ben-Neriah and Karin,
2011). The inflammatory tumor process is actually added as
a distinct cancer hallmark (Hanahan and Weinberg, 2011).
Recent studies suggested that both the whole colon microbiota
and specific pathogenic microbial strains likely play a crucial
role in CRC development, in both direct and indirect ways
(Candela et al., 2014; Lin and Zhang, 2017). In this context,
Fusobacterium nucleatum appears to be particularly interesting.
Indeed this nonspore-forming, anaerobic gram-negative oral
commensal bacterium, is linked to periodontal disease, but
several reports have shown a correlation with a wide range of
disorders, including gastrointestinal and cardiovascular diseases,
rheumatoid arthritis, respiratory tract infections, and Alzheimer’s
disease (for a review see Han, 2015). Furthermore, it is
increasingly emerging that members of Fusobacterium genus,
in particular F. nucleatum, inhabit stool and tumor tissues
samples of patients affected by the CRC and colorectal adenomas
(Ito et al., 2015). On the other hand, few studies suggested a
correlation between F. nucleatum and colon cancer invasiveness
(e.g., lymph node metastasis); however, this hypothesis has not
been completely corroborated (Castellarin et al., 2012; Flanagan
et al., 2014), even though an enrichment of F. nucleatum in
CRC tissue has been detected, by both metagenomic and qPCR
analyses of DNA from feces (Kostic et al., 2012).
In this study we used targeted metagenomics based on
16S rRNA gene to deeply explore three different human
districts trying to define possible microbial markers of CRC not
exclusively related to the tumor lesion.
MATERIALS AND METHODS
Patients
In total, 10 Italian patients (four males and six females with
an age range of 71–95 years) with colorectal adenocarcinoma
(confirmed by histological analysis), undergoing surgical
resections at the Unit of Surgery, University Hospital of Careggi
(AOUC), University of Florence, between October 2015 and
March 2016 and 10 healthy controls (six males and four females
with an age range of 63–86 years) were recruited. The patients
with other CRCs, or exposed to antibiotic therapy within 3
months prior to sample collection, as well those who have
undertaken radiotherapy and chemotherapy before the surgical
resection and those with comorbid malignancies of other organs
were excluded. The 10 healthy subjects were selected based
on age, and body mass index, no gastrointestinal disorders,
no antibiotic use during the 3-month period prior to sample
collection. All the 10 CRC patients were divided according
to the pathological TNM (tumor-Node-Metastasis) staging
system 7th edition and Dukes classification (Williams and Beart,
1992). The TNM classification uses three parameters to divide
the patients into different stages: depth of tumor penetration
into the gastric wall (T parameter), the number of metastatic
regional lymph nodes involved (N parameter) and the presence
of distant metastases (M parameter). Data collected included
anthropometric measurements (height, weight), nutritional data
(including the use of probiotics), clinical history and status and
medication history (Table 1 and Table S1).
Unstimulated saliva and stool were collected from both
patients and healthy controls, while CT samples were collected
only from CRC patients. The day before surgery, in the early
morning, saliva was collected by spitting after 1min without
swallowing into a sterile tube; stool samples were collected in a
sterile container. CT samples were collected in sterile conditions
during surgery. The oral health status of the patients was
assessed as it can have a major impact on the salivary microbiota
(Table S1). For ethical reasons, we collected only saliva and
stool samples from healthy controls. After collection, saliva and
stool samples were immediately frozen and stored at −80◦C
until DNA extraction. Fresh CRC tissues from each patient were
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TABLE 1 | Clinical parameters of CRC patients (CM) and healthy controls (CFP).
Code Age
range
Diagnosis TNM Tumor
site
Height
(m)
Weight
(Kg)
BMI
CM7 75–80 1 pT3 N0 Mx Colon 1.55 50 20.81
CM8 75–80 2 pT1 N0 Colon 1.57 60 23.34
CM10 75–80 1 pT3 N2a Mx Colon 1.70 70 24.22
CM11 85–90 1 pT3 N0 Mx Colon 1.70 67 23.18
CM18 80–85 1 pT3 N1b Mx Colon 1.80 87 26.85
CM19 95–100 3 pT3 N1b Mx Colon 1.60 62 24.22
CM20 75–80 1 pT1 N0 Colon 1.75 55 17.96
CM22 80–85 1 pT3 N1a Mx Colon 1.63 53 19.95
CM23 75–80 2 pT2 N0 Rectum 1.66 67 24.31
CM24 70–75 2 pT3 N2b M1 Sigma-
Rectum
1.59 86 34.02
CFP1 80–85 1.66 59 21.41
CFP2 70–75 1.80 82 25.31
CFP3 80–85 1.73 100 33.41
CFP4 75–80 1.70 64 22.15
CFP6 80–85 1.68 62 21.97
CFP7 60–65 1.68 65 23.08
CFP8 70–75 1.86 94 27.17
CFP9 80–85 1.80 82 25.31
CFP10 70–75 1.88 76 21.50
CFP11 80–85 1.70 85 29.41
TNM (Tumor-Node-Metastasis) staging system 7th (Williams and Beart, 1992). BMI, Body
Mass Index; Diagnosis: 1= Intestinal Adenocarcinomamedium differentiate; 2= Intestinal
Adenocarcinoma moderate differentiate; 3 = Tubulo-villous adenoma with intestinal
epithelial dysplasia; Put underneath≪ Patients≫ in Materials and methods.
collected in physiological solution (NaCl 0.9%). Samples were
stored at −80◦ until use. The study protocols were approved by
the ethics committee of AOUC Careggi and complied with the
“Declaration of Helsinki.” A written approval was obtained from
each participant.
Bacterial DNA Extraction
DNA was extracted from all samples using PowerLyzer R©
PowerSoil R© DNA Isolation Kit (MO BIO laboratories, Inc.,
Carlsbad, California, USA) with some modifications to the
manufacturer’s instructions for fecal and saliva samples (Gao
et al., 2015).
The modifications were performed on fecal samples as follows
(Wesolowska-Andersen et al., 2014): 0.5 g of each stool sample
was treated with 2.5ml of PowerSoil R© Bead Solution. Samples
were vortexed and then centrifuged at room temperature for
5min at 1,500 × g. 1ml of the supernatant was transferred to
a PowerLyzer R© Glass Bead Tube and 750ml of PowerSoil R© Bead
Solution were added. Each sample was incubated for 10min at
65◦C and then for 10min at 95◦C. By this step, manufacturer’s
instructions were followed.
The modifications on saliva samples were performed as
follows (Aagaard et al., 2013): 2ml of each saliva sample was
centrifuged at room temperature for 15min at 2,600 g. The pellet
was resuspended with 750 µl of the PowerSoil R© Bead Solution.
Then, the sample was loaded into the PowerLyzer R© Glass Bead
Tube according to the manufacturer’s instructions.
Quantity and purity of extracted DNA were checked by 0.8%
agarose gel electrophoresis in Tris-EDTA buffer. Each sample was
then quantified with the Qubit fluorometer (Life Technologies).
All DNA samples were stored at−20◦C until used.
16S rRNA Gene Analysis
Extracted DNA samples were sent to an external company
(IGA Technology Services-Udine-Italy) for library construction
and sequencing on the MiSeq Illumina platform with paired-
end protocol. In particular, the V3-V4 region of bacterial
16S rRNA gene was amplified via PCR using specific primers
(806R and 515F) as previously described (Checcucci et al.,
2016). Raw sequences were processed following the UPARSE
pipeline (Edgar, 2013). First, sequences were quality refined using
StreamingTrim 1.0 (Bacci et al., 2014). Low quality segments
were removed using a quality cutoff of 18 Phreds whereas
constructs that might have been generated during sequencing
procedures, were removed only if found in the top 50 residues
of each sequence. Mate pairs were subsequently assembled using
the “fastq_mergepairs” command of the USEARCH suite (Edgar
et al., 2011). About 92% of the initial pairs were correctly
merged, collecting more than 12 million sequences. Sequences
were additionally filtered using the “fastq_filter” command
of the USEARCH suite with a maximum error rate of 1.0
and a fixed length of 300 bp. Identical sequences were then
merged (de-replication) and singleton sequences, namely those
found only one time, were removed to reduce errors due to
the amplification process (Morgan et al., 2014). De-replicated
sequences with an identity higher than 97% were pooled
together using the “cluster_otus” commands of the USEARCH
suite. Putative chimeric sequences were automatically detected
during this step, but an additional chimeric identification step
was also included, using the “uchime_ref” command (Edgar
et al., 2011) in combination with the latest RDP training
set available (trainset16 02/2016) (Cole et al., 2014). Finally,
17′971 representative sequences were collected and used as
reference for the clustering step that was performed using
the “-usearch_global” command of the USEARCH suite with
a sequence identity threshold of 97% (corresponding to the
species level according to Konstantinidis and Tiedje (2007). More
than 72% of the initial sequences were correctly assigned to an
OTU (8′595′385 sequences). For each OTU (cluster), a single
representative sequence was used for taxonomic annotation.
Sequences were classified using the SINA standalone classifier in
combinationwith the “Ref NR 99” database (release 123) (Pruesse
et al., 2012). Clusters classified as “Eukaryota” were removed
along with unclassified clusters retaining a set of 2,386 clusters
classified as “Bacteria” or “Archaea.” A detailed description of the
number of sequences collected at each step of analysis is reported
in Table S2.
Real-Time Quantitative PCR
To estimate the relative amount of F. nucleatum over the
total amount of bacteria, the DNA from each sample
was assayed by real-time quantitative PCR (qPCR); the
estimation of the total number of 16S rRNA gene copies in
all samples was performed with bacterial primers Eub341F
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(5′- CCTACGGGAGGCAGCAG-3′) and Eub515R (5′-
TACCGCGGCKGCTGGCA-3′) targeting the 16S rRNA
gene, using a previously reported protocol (Abdelrhman et al.,
2016); the value of F. nucleatum was assessed with specific
primers: fuso-F (5′-CTTAGGAATGAGACAGAGATG-3′) and
fuso-R (5′-TGATGGTAACATACGAAAGG-3′) (Periasamy and
Kolenbrander, 2009), targeting a fragment of 16S rRNA gene.
qPCR was performed in an QuantStudioTM 7 apparatus (Applied
Biosystems), following the amplification program described
in Periasamy and Kolenbrander (2009). F. nucleatum DSM
20482 (ATCC 10953) DNA was used as standard for qPCR
quantification. Reactions were performed in triplicates in 10
µl final volume as described in Checcucci et al. (2016). qPCR
results were analyzed by comparing the Cq values of the samples,
representing the threshold cycles; Cq is a relative measure of
the concentration of the target gene in the PCR reaction; lower
Cq values indicate high amounts of targeted nucleic acid, while
higher Cq values indicate lower amounts of the target nucleic
FIGURE 1 | Taxonomic composition of CRC patient (and healthy controls) microbiota. Relative abundances bar plot showing the relative abundance of bacterial phyla
in each sample. All phyla representing less than 5% of the total reads analyzed were included in the “Other” group.
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acid. The presence of F. nucleatum has been calculated as the
ratio between the Cq value of F. nucleatum 16S rRNA gene and
the Cq value of the total bacterial community 16S rRNA gene
amplicons. The results were analyzed with the Mann-Whitney
pairwise post-hoc tests, using the PAST3 Software (Hammer
et al., 2001).
Statistical Analysis
Statistical analyses on the bacterial community distribution
were implemented in R (R Core Team, 2014) using the vegan
package (version 2.3-2) (Oksanen et al., 2015). Analysis of
similarity (ANOSIM, “anosim” function) was conducted to
test the statistical significance of difference between distinctive
bacterial communities.
Microbiome dataset was analyzed in R (R Core Team,
2014) with the help of additional libraries as reported below.
Accumulation curves were calculated using the “specaccum”
function (vegan package version 2.4) (Oksanen et al., 2015)
adding sites in random order with 100 permutations for each
step. Differences in bacterial population structure between
different body sites were inspected using the “anosim” function
(vegan package) with 1,000 permutations and plotted using
the ggplot2 library (version 2.2) (Wickham, 2009). Hierarchical
clustering of bacterial distribution was performed based on the
average linkage method with Bray-Curtis dissimilarity indexes
(“vegdist” function, vegan package) and visualized using custom
scripts. OTU counts were normalized for each sample by dividing
them by the total counts of all OTUs within that sample.
Differences in the abundance of OTUs assigned to Fusobacterium
genus between CRC and healthy patients were inferred using
FIGURE 2 | Species accumulation curves of healthy and CRC patients for
each sampling body site. CT samples seem to have the highest alpha diversity
whereas the bacterial diversity of CRC patients and controls is similar within
each body site.
Student’s t-test on normalized data (“t-test” function of the R
stats package). The distribution of Fusobacterium representatives
in biopsy samples of CRC patients was modeled using linear
models and one-way analysis of variance (“lm” and “aov”
functions of stats Package) on quantitative and qualitative
factors, respectively. The LEfSe pipeline (Segata et al., 2011)
was performed on OTU count collapsed according to shared
taxonomic classifications to identify distinctive taxa of each
body site here explored (saliva, feces, and biopsy). Differentially
abundant OTUs were detected using differential abundance
analysis with a zero-inflated log-normalmodel as implemented in
the “fitFeatureModel” function of themetagenomeSeq R package,
version 1.16 (Paulson et al., 2013).
Shannon, Chao 1, Evenness and Richness indices were used
to estimate bacterial diversity in each sample (Tables S6, S7).
The indices were computed using the “diversity” function of the
vegan R package version 2.4. The percentage of coverage was
calculated by Good’s estimator (Good, 1953) using the formula:
[1—(n/N)] × 100, where n is the number of sequences found
once in a sample (singletons), and N is the total number of
sequences in that sample. The Evenness index was calculated
using the formula E = S/log(R), where S is the Shannon
diversity index and R is the number of OTUs in the sample
(the Richness). Different alpha diversity values were tested using
mixed-effect model since our data contained observations that
were not necessarily independent of one another, namely the
patients (West et al., 2014). The “lme” function of the nlme
R package (version 3.1) (Pinheiro et al., 2016) was used to
construct a model for each diversity index measured (Table S3) to
inspect different diversity level across different environment and
between healthy and CRC patients. A random intercept model
was built using subject ids as a random effect for each index
considered.
Accession Number
The 16S rRNA gene sequence data generated in this study was
submitted to the GenBank Sequence Read Archive accession
number PRJNA356414.
Ethics Approval and Consent to Participate
The study was reviewed and approved by AOUC Careggi
Institutional Review Board (Prot 2010/0012462). All study
participants, or their legal guardian, have provided an informed
written consent prior to the study enrollment in compliance
with national legislation and the Code of Ethical Principles
for Medical Research Involving Human Subjects of the World
Medical Association (Declaration of Helsinki).
RESULTS
Overall Comparison of the Oral, Fecal, and
Cancer Tissue Microbiota
We examined the oral cavity and gut (feces and cancer tissue)
bacterial communities of 10 patients with CRC and 10 age-
and healthy-controls (Table S1). A dataset of 8,595,385 high-
quality 16S rRNA sequences (n = 20 patient and control fecal
samples, n = 20 patient and control saliva samples, n = 10
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CT samples) was obtained. The final data set included 574
bacterial genera belonging to 36 different phyla with a different
distribution across samples (Figure 1). Samples reported a
Good’s coverage estimator ranging from 99 to 100% indicating
that roughly 1% of the reads in a given sample came from OTUs
that appear only once in that sample (Table S3). The alpha
diversity of samples from healthy patients and samples from
CRC patients did not report significant differences. However, at
body site level differences were observed. In particular, biopsy
samples showed a higher level of both Shannon index and
Evenness (Kruskal-Wallis test, χ2 = 9.9, p-values = 0.007
for Shannon index, and χ2 = 10.9, p-values = 0.004 for
Evenness). The highest value of Evenness in biopsy samples
together with the highest value of Shannon index revealed a high
complexity of this environment. The analysis of the taxonomic
composition revealed that more than 85% of the sequences
collected were classified into five phyla: Firmicutes (39.18%),
Bacteroidetes (30.36%), Proteobacteria (10.65%), Fusobacteria
(5.15%), and Actinobacteria (4.22%). Differences in bacterial
community composition were assessed using the analysis of
similarity (ANOSIM function with 1,000 permutations). The
different body sites showed different bacterial compositions
(R = 0.834, P = 0.001), along with feces samples coming from
controls and CRC patients (R = 0.201, P = 0.005). CT samples
exhibited a composition of bacterial communities different from
that present in stool samples in CRC patients (R = 0.61,
P = 0.001). Accumulation curves reported in Figure 2 showed
a different biodiversity level across body sites. In particular
biopsy samples of patients affected by CRC were the ones
reporting the highest level of bacterial diversity as confirmed
by Kruskall-Wallis test reported in Figure 3. Hierarchical cluster
analysis based on the log transformed abundances of OTUs
showed that saliva samples are clustered together confirming that
there is no statistical difference between the microbiota of CRC
and healthy patients inhabiting this compartment (ANOSIM
analysis: R = 0.049, P = 0.176). CT samples showed the highest
alpha diversity value compared to other body sites, whereas the
taxonomic diversity of samples from CRC and healthy patients
was similar within the same body site (Table S4 and Figure 3).
In contrast, CT samples seem to have a distinct pattern of
bacterial distribution as reported in Figure 4 (cluster 3) with
a wide distribution of bacterial genera belonging to the major
phyla previously detected (Proteobacteria, Bacteroidetes, and
Firmicutes).
FIGURE 3 | Biodiversity indices distribution according to sampling site and patient status. Patients with CRC and healthy ones reported similar diversity values for all
the indices considered. CRC patients showed higher values of alpha diversity in biopsy samples. Asterisks indicate a significant Kruskal-Wallis test with alpha = 0.05.
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FIGURE 4 | Microbiota distribution for each analyzed sample. (A) The number of reads assigned to each OTU was log transformed and reported using the color scale
whereas sampling body sites were reported with different colors (red for biopsy samples, blue for stool samples, and green for saliva samples). Dendrograms were
produced with average clustering method (UPGMA) based on Bray-Curtis distance. Clusters of OTUs were assessed cutting the dendrogram at 0.95 height. (B) The
relative abundance of OTUs belonging to cluster 3 was collapsed at Genus level taking into account only the biopsy samples. Genera with an abundance lower than
1% were removed from the analysis. Relative abundance was computed dividing the number of 16S sequences assigned to each OTU by the total number of
sequences obtained for each sample. Boxes denote the interquartile range (IQR) between the 25th and the 75th percentile (first and third quartiles), whereas the inner
line represents the median. Whiskers represent the lowest and highest values within 1.5 times IQR from the first and third quartiles Outliers were reported using white
circles.
qPCR Assay and Association of
F. nucleatum Colonization with
Clinicopathologic Features of CRC
Patients
Several studies in literature suggested the role of F. nucleatum
as cancer-promoting bacteria (Castellarin et al., 2012; Kostic
et al., 2012; Flanagan et al., 2014; Ito et al., 2015; Ramos
and Hemann, 2017). Members of Fusobacterium genus were
detected through 16S rRNA analysis but this approach did
not allow us to reach species resolution; thus we decided to
further investigate the distribution of this genus using qPCR
to confirm the presence of members of F. nucleatum species.
In Figure 5, the quantification of F. nucleatum expressed as
the ratio between the Cq value of F. nucleatum 16S rRNA
gene, and the Cq value of the total bacterial community 16S
rRNA gene amplicons is reported. Consequently, the lowest ratio
values indicate higher F. nucleatum abundance in the samples.
No significant differences between stool samples of healthy
subjects and stool samples of CRC patients were observed (Table
S5). Moreover, neither statistically significant differences were
evidenced between saliva samples of healthy and CRC subjects.
However, results highlighted that F. nucleatum abundance is
higher in saliva than stool samples both in healthy subjects (p <
0.002) and in CRC patients (p < 0.01).
NGS 16S rRNA data were then analyzed, taking into account
all OTUs assigned to Fusobacterium genus. A search over the
GenBank database by using the BLAST algorithm sorted out
that all but OTU 300, matched with F. nucleatum sequences in
the top-10 hits with an identity threshold ≥95%, confirming the
feasibility of using NGS data for F. nucleatum DNA detection in
our samples. Obtained results (Figure 6) confirmed qPCR data,
revealing that stool samples had the lowest number of reads
assigned to this genus in contrast with CT samples, which showed
the highest number of sequences related to Fusobacterium genus.
Neither NGS data were underlining differences between healthy
controls and CRC patients.
Distinct Taxonomic Distribution in Different
Body Sites
Linear discriminant analysis revealed a distinct microbial
distribution in regard of sampling site (Figure 7A). In
particular, saliva samples were mainly enriched in members
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FIGURE 5 | qPCR results for quantification of F. nucleatum respect to the total bacterial community; quantification is expressed as the ratio between the Cq value of
F. nucleatum 16S rRNA gene and the Cq value of the total bacterial community 16S rRNA gene amplicons. The higher is the ratio value, the lowest is the
quantification of the target amplicon in the sample.
of Actinobacteria, Saccharibacteria, Proteobacteria (Beta class),
Fusobacteria, Firmicutes (mainly Negativicutes and Bacilli),
and Bacteroidetes (exclusively represented by members of
Flavobacteriia class and Prevotellaceae family) whereas stool
samples presented a characteristic distribution of Bacteroidetes
(in particular the Bacteroidia class) and Firmicutes (mainly
Clostridia and Erysipelotrichia classes). Interestingly, biopsy
samples were characterized by members of Proteobacteria,
mainly Delta, Alpha, and Gamma classes, Planctomycetes, and
Firmicutes (namely Lachnospiraceae family and Clostridiales
family XI). Despite the increased abundance of members of
Fusobacteria in saliva samples (Figure 7B), biopsy samples were
enriched in members of Fusobacterium genus (Figure 7C).
Interestingly, only one OTU classified as Fusobacterium was
detected in cluster 3 (Figure 4A) reporting a mean abundance
lower than 1%. On the contrary, collapsed counts based on
shared taxonomic classifications showed a higher presence of
members of Fusobacterium genus (2.9% in the whole dataset) and
an even higher abundance in biopsy samples (5.9%, Figure 7C).
DISCUSSION
Comparison of Oral and Intestinal
Microbiota in CRC Patients vs. Healthy
Controls
The aim of this study was to explore, characterize, and
compare the bacterial community composition in different body
compartments (saliva, stool, and cancer tissue) of CRC Italian
patients, through the NGS analysis. Data obtained revealed that
the bacterial communities of the three analyzed body sites of
both CRC patients and healthy individuals differed significantly
in terms of bacterial community composition: the analysis of
similarity showed different bacterial taxonomic compositions in
saliva, stool, and biopsy. In addition, also linear discriminant
analysis (performed with the “lefse“ pipeline to detect distinctive
taxa of saliva, feces, and biopsy) revealed a distinct microbial
distribution with respect to sampling sites. According to previous
studies (Gao et al., 2015), the relative richness values of dominant
phyla Bacteroidetes, Firmicutes, and Proteobacteria were all
different in both CRC patients and healthy controls.
Saliva is a biological fluid that could be suitable for biomarker
detection. The average adult produces more than 1,000ml of
saliva per day, which always flows into the gastrointestinal
tract, thus, the salivary microbiota affects the development
of intestinal microbiota in some respects. Our study shows
that the microbial community of saliva is, as expected, very
different from that inhabiting the other two body sites of the
same patient. Variations of the salivary microbiota composition
in oral health and disease conditions have been previously
described (Belstrøm, 2015), suggesting that the oral microbial
compositions may theoretically reflect the oral and general
health status. According to previous data (Aas et al., 2005;
Keijser et al., 2008; Lazarevic et al., 2009; Nasidze et al., 2009;
Bik et al., 2010), we observed that sequences affiliated to the
phylum Firmicutes dominates the bacterial communities in
saliva samples, even though no significant difference was found
between CRC patients and healthy controls The application
of the linear discriminant analysis, showed an enrichment
in members of Actinobacteria, Saccharibacteria, Proteobacteria
(Beta class), Fusobacteria, Firmicutes (mainly Negativicutes and
Bacilli), and Bacteroidetes (exclusively represented bymembers of
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FIGURE 6 | Barplots reporting the average number of sequences assigned to each OTU classified as Fusobacterium. Error bars represent the 95% confidence
interval of the distribution.
Flavobacteriia class and Prevotellaceae family) in saliva samples.
In particular, we observed an enrichment of Fusobacteria,
in agreement with previously reported data (Bolstad et al.,
1996). Stool samples exhibited a characteristic distribution of
Bacteroidetes (in particular the Bacteroidia class) and Firmicutes
(mainly Clostridia and Erysipelotrichia classes).
Our data suggest that bacterial communities and CRC
might be further investigated for their possible correlations
in order to assess the opportunity of detecting colon cancer
through the analysis of specific fecal bacterial markers. In
particular, the fecal-associated microbiota could be dynamically
linked to colon cancer, which, in turn, may offer evidence
for microflora-associated diagnostic, preventive, prognostic and
therapeutic approaches for CRC. However, it is clear that
additional studies will be required before a complete examination
of these findings.
Because of the prognostic relevance of CRC detection
and the prospective testing of fecal samples for bacterial
biomarkers, we evaluated whether fecal microbiota profiles
mirrored those findings for the colon mucosa tissue. For
ethical reasons, healthy intestinal biopsies were not included
in the pilot study; accordingly, only few studies evaluating
the CRC mucosal microbial community included healthy
individuals as controls (Dejea et al., 2014; Geng et al., 2014).
As expected, we found that the microbiota compositions in
neoplastic tissue significantly diverge from the intestinal lumen
(stool) one, in agreement with Flemer et al. (2017). The
relative abundance of dominant phyla Firmicutes, Bacteroidetes,
Proteobacteria, Fusobacteria were all different in the two
examined body sites (cancer tissue and stool). In particular,
Proteobacteria and Fusobacteria were more abundant in
cancer specimens, while a significantly higher abundance of
Firmicutes and Fusobacteria were observed in the stools of CRC
patients.
F. nucleatum Colonization in Patients with
CRC vs. Healthy Controls
The presence of F. nucleatum in saliva, tumor tissue, and
stool samples was investigated. It is not yet clear whether
the presence of particular bacteria (not yet known) in the
neoplastic microenvironment is indicative of a causative role
in the CRC genesis and development (Gao et al., 2015). It has
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FIGURE 7 | Linear discriminant analysis of association between sampling sites and microbial taxa. A linear discriminant analysis was performed using Lefse and
considering the three body sites sampled in this study, namely: biopsy (red), saliva (green), and stool (blue). (A) Different body sites showed a characteristic taxonomic
composition with major clades strongly associated with a particular site. Proteobacteria were mostly associated with biopsy samples whereas Fusobacteria and
Bacteroidetes were mainly associated with saliva and stool samples, respectively. (B) Saliva samples reported highest values of Fusobacteria members even if (C)
Fusobacterium genus was mainly found in biopsy samples. Each body site has been represented using different colors (A) whereas the relative abundance of
Fusobacteria (B) and Fusobacterium clade (C) was reported for each subject. Samples coming from control and CRC patients were reported below (B,C).
Frontiers in Microbiology | www.frontiersin.org 10 January 2018 | Volume 8 | Article 2699
Russo et al. Oral and Intestinal Microbiota Characterization
been previously suggested that the intestinal dysbiosis resulted
in different types of colorectal pathologies, as well as CRC,
but no specific direct link with the presence of this bacterium
has been established (Tremaroli and Bäckhed, 2012; Allen-
Vercoe and Jobin, 2014). Recently, NGS investigations provided
much significant evidence in this CRC field, especially about
the association of F. nucleatum with CRC. This bacterium
is not a predominant species in stool samples and has been
observed in cancer biopsies of CRC subjects by two independent
research groups. Using whole-genome sequencing techniques,
an enrichment of Fusobacterium spp. was observed, DNA
sequences were detected in CT samples compared with the
control ones (Kostic et al., 2012). Notably, among them, the most
represented phylotype was F. nucleatum. On the other hand,
using RNA-sequencing approaches, the group of Castellarin et al.
(2012) detected a richness of Fusobacterium spp. in CRC vs.
healthy tissues. On these premises, the two research groups
have proposed a direct link between this bacterium and CRC
pathogenesis. F. nucleatum is commonly found in periodontal
plaque and, in the oral cavity, it is associated with viruses,
which adhere to host tissue cells influencing the host’s immune
response (Bolstad et al., 1996). As expected qPCR data (Figure 5)
highlighted that in saliva samples the presence of F. nucleatum
is higher (with respect to total bacterial) than in stool (Bolstad
et al., 1996). However, we cannot a priori exclude the possibility
that our analysis detected also a mixture of closely related
(and potentially still unknown) Fusobacterium strains/species.
F. nucleatum is a key player in modifying intestinal inflammation
levels (Rubinstein et al., 2013). In addition, in a study about
colorectal adenomas, the abundance of F. nucleatumwas found to
positively correlate with inflammatory cytokine gene expression
such as TNF (McCoy et al., 2013). TNF-α is produced during the
inflammatory response and can promote survival, attachment,
and proliferation of metastatic colon cancer cells in a mouse
model of lung metastasis depending on the activation of NF-κB
by inflammation and cancer cells (Luo et al., 2004). Moreover,
through activation of NF-κB and STAT3, TNF-α can enhance
epithelial-mesenchymal transition which are critical steps that
allow polarized epithelial tumor cells to become mesenchymal
like, enhancing cell migration and invasion (Yang andWeinberg,
2008). In light of possible roles of F. nucleatum in downregulating
T cell-mediated antitumor immune responses (Kostic et al.,
2013) and in promoting colorectal tumor progression, future
investigations on a larger number of patients may be warranted
to explore the impact of F. nucleatum on the T cell-based
immunotherapy efficacy for CRC.
CONCLUSIONS
Here, we demonstrated a different bacterial taxonomic
composition in CRC stool samples vs. healthy controls. We
are aware that this study may suffer some limitations, such as
the restricted number of enrolled patients, the not complete
assessment of the oral health status (that might influence the
composition of oral microbiota) and the lack of evaluation
of other intestinal bacterial species (e.g., Escherichia coli and
Bacteroides fragilis) (Arthur et al., 2012). In spite of this, our
pilot study represents the first simultaneous comparison of the
microbial compositions of the tree different body sites (saliva,
stool, CT samples). Analyzing a single body niche to categorize
CRC individuals does not enable researchers to comprehensively
study the spatial variations of the microbiota in CRC. Therefore,
the proposed strategy of characterizing the spatial community
structures of CRC microbiota (according to Zhang et al., 2017)
is crucial to improve our understanding of the mutual interplay
between microflora and CRC presence.
However, to further validate these findings and to extend
our knowledge about the variation of bacterial composition
as a function of CRC (and vice versa), it will be helpful to
account for a larger number of patients with longitudinal
time points. This will promote the development of novel
microbial-related diagnostic instruments and therapeutic
approaches.
AVAILABILITY OF DATA AND MATERIALS
The partial 16S rRNA gene sequence data generated in this study
were submitted to the GenBank Sequence ReadArchive accession
number PRJNA356414.
AUTHOR CONTRIBUTIONS
ER, RF, AA, and AM designed the research; AT, MR, EN,
FR, FM, MM, and RB collected the samples; ER, CC, and CF
performed the experiments; GB analyzed the data; ER, GB, CC,
and CF wrote the paper; ER, AA, RF, AM, and PB supervised all
the experimental work and revised the manuscript; all authors
critically read and approved the manuscript.
FUNDING
The research was founded with a grant from the regional
contribution of “The Programma Attuativo Regionale (Toscana)
funded by FAS (now FSC), the Italian Ministry of University
and Research (MIUR) and the Foundation ‘Ente Cassa di
Risparmio di Firenze.’ CC, CF, GB, RB, and ER were granted
by FAS.
ACKNOWLEDGMENTS
The authors thank to all the CRC patients enrolled the Unit of
Surgery, University Hospital of Careggi (AOUC), University of
Florence, and the healthy controls. The authors thank Dr. Mirella
Vivoli for the valuable help in revising the manuscript. We are
also very grateful to referees for their comments and suggestions
in improving the manuscript.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fmicb.
2017.02699/full#supplementary-material
Frontiers in Microbiology | www.frontiersin.org 11 January 2018 | Volume 8 | Article 2699
Russo et al. Oral and Intestinal Microbiota Characterization
REFERENCES
Aagaard, K., Petrosino, J., Keitel, W., Watson, M., Katancik, J., Garcia, N., et al.
(2013). The human microbiome project strategy for comprehensive sampling
of the human microbiome and why it matters. FASEB J. 7, 1012–1022.
doi: 10.1096/fj.12-220806
Aas, J. A., Paster, B. J., Stokes, L. N., Olsen, I., and Dewhirst, F. E. (2005). Defining
the normal bacterial flora of the oral cavity. J. Clin. Microbiol. 43, 5721–5732.
doi: 10.1128/JCM.43.11.5721-5732.2005
Abdelrhman, K. F. A., Bacci, G., Mancusi, C., Mengoni, A., Serena, F., and Ugolini,
A. (2016). A first insight into the gut microbiota of the sea turtleCaretta caretta.
Front. Microbiol. 7:1060. doi: 10.3389/fmicb.2016.01060
Akin, H., and Tözün, N. (2014). Diet, microbiota, and colorectal cancer. J. Clin.
Gastroenterol. 48(Suppl. 1), S67–S69. doi: 10.1097/MCG.0000000000000252
Allen-Vercoe, E., and Jobin, C. (2014). Fusobacterium and Enterobacteriaceae:
important players for CRC? Immunol. Lett. 162, 54–61.
doi: 10.1016/j.imlet.2014.05.014
Amedei, A., Munari, F., Bella, C. D., Niccolai, E., Benagiano, M., Bencini, L., et al.
(2014). Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives
Th17 inflammation in gastric adenocarcinoma. Intern. Emerg. Med. 9, 303–309.
doi: 10.1007/s11739-012-0867-9
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan,
T. J., et al. (2012). Intestinal inflammation targets cancer inducing activity of the
microbiota. Science 338, 120–123. doi: 10.1126/science.1224820
Bacci, G., Bazzicalupo, M., Benedetti, A., and Mengoni, A. (2014).
StreamingTrim 1.0: a java software for dynamic trimming of 16S rRNA
sequence data from metagenetic studies. Mol. Ecol. Resour. 14, 426–434.
doi: 10.1111/1755-0998.12187
Belstrøm, D. (2015). “Salivary microbiota in oral health and disease,” in Oral
Infections and General Health: FromMolecule to Chairside, ed A.M. L. Pedersen
(Cham: Springer), 115–122.
Ben-Neriah, Y., and Karin, M. (2011). Inflammation meets cancer, with NF-κB as
the matchmaker. Nat. Immunol. 12, 715–723. doi: 10.1038/ni.2060
Bik, E. M., Long, C. D., Armitage, G. C., Loomer, P., Emerson, J., Mongodin, E.
F., et al. (2010). Bacterial diversity in the oral cavity of 10 healthy individuals.
ISME J. 4, 962–974. doi: 10.1038/ismej.2010.30
Bolstad, A. I., Jensen, H. B., and Bakken, V. (1996). Taxonomy, biology, and
periodontal aspects of Fusobacterium nucleatum. Clin.Microbiol. Rev. 9, 55–71.
Candela, M., Turroni, S., Biagi, E., Carbonero, F., Rampelli, S., Fiorentini, C., et al.
(2014). Inflammation and colorectal cancer, when microbiota-host mutualism
breaks.World J. Gastroenterol. 20, 908–922. doi: 10.3748/wjg.v20.i4.908
Castellarin,. M.,Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss,
J., et al. (2012). Fusobacterium nucleatum infection is prevalent in human
colorectal carcinoma. Genome Res. 22, 299–306. doi: 10.1101/gr.126516.111
Checcucci, A., Azzarello, E., Bazzicalupo, M., Galardini, M., Lagomarsino, A.,
Mancuso, S., et al. (2016). Mixed nodule infection in Sinorhizobium meliloti-
medicago sativa symbiosis suggest the presence of cheating behavior. Front.
Plant Sci. 7:835. doi: 10.3389/fpls.2016.00835
Cole, J. R., Wang, Q., Fish, J. A., Chai, B., McGarrell, D. M., Sun, Y., et al. (2014).
Ribosomal database project: data and tools for high throughput rRNA analysis.
Nucleic Acids Res. 42, D633–D642. doi: 10.1093/nar/gkt1244
Dejea, C. M., Wick, E. C., Hechenbleikner, E. M., White, J. R., Mark Welch, J.
L., Rossetti, B. J., et al. (2014). Microbiota organization is a distinct feature
of proximal colorectal cancers. Proc. Natl. Acad. Sci. U.S.A. 111, 18321–18326.
doi: 10.1073/pnas.1406199111
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent,
M., et al. (2005). Diversity of the human intestinal microbial flora. Science 308,
1635–1638. doi: 10.1126/science.1110591
Edgar, R. C. (2013). UPARSE: highly accurate OTU sequences from microbial
amplicon reads. Nat. Methods 10, 996–998. doi: 10.1038/nmeth.2604
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., and Knight, R. (2011).
UCHIME improves sensitivity and speed of chimera detection. Bioinformatics
27, 2194–2200. doi: 10.1093/bioinformatics/btr381
Flanagan, L., Schmid, J., Ebert, M., Soucek, P., Kunicka, T., Liska, V., et al.
(2014). Fusobacterium nucleatum associates with stages of colorectal neoplasia
development, colorectal cancer and disease outcome. Eur. J. Clin. Microbiol.
Infect. Dis. 33, 1381–1390. doi: 10.1007/s10096-014-2081-3
Flemer, B., Lynch, D. B., Brown, J. M., Jeffery, I. B., Ryan, F. J., Claesson, M.
J., et al. (2017). Tumour-associated and non-tumour-associated microbiota in
colorectal cancer. Gut 66, 633–643. doi: 10.1136/gutjnl-2015-309595
Gao, R., Gao, Z., Huang, L., and Qin, H. (2017). Gut microbiota and
colorectal cancer. Eur. J. Clin. Microbiol. Infect. Dis. 36, 757–769.
doi: 10.1007/s10096-016-2881-8
Gao, Z., Guo, B., Gao, R., Zhu, Q., and Qin, H. (2015). Microbiota
disbiosis is associated with colorectal cancer. Front. Microbiol. 6:20.
doi: 10.3389/fmicb.2015.00020
Geng, J., Song, Q., Tang, X., Liang, X., Fan, H., Peng, H., et al. (2014).
Co-occurrence of driver and passenger bacteria in human colorectal cancer.
Gut Pathog. 6:26. doi: 10.1186/1757-4749-6-26
Good, I. J. (1953). The population frequencies of species and the
estimation of population parameters. Biometrika 40, 237–264.
doi: 10.1093/biomet/40.3-4.237
Hammer, Ø., Harper, D. A. T., and, P. D., Ryan, (2001). PAST: paleontological
statistics software package for education and data analysis. Palaeontol.
Electronica 4:9
Han, Y. W. (2015). Fusobacterium nucleatum: a commensal-turned pathogen.
Curr. Opin. 23, 141–147. doi: 10.1016/j.mib.2014.11.013
Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer: the next
generation. Cell 144, 646–674. doi: 10.1016/j.cell.2011.02.013
Ito,M., Kanno, S., Nosho, K., Sukawa, Y.,Mitsuhashi, K., Kurihara, H., et al. (2015).
Association of Fusobacterium nucleatum with clinical and molecular features
in colorectal serrated pathway: F. nucleatum and molecular features of serrated
lesions. Int. J. Cancer 137, 1258–1268. doi: 10.1002/ijc.29488
Keijser, B. J., Zaura, E., Huse, S. M., van der Vossen, J. M., Schuren, F. H., Montijn,
R. C., et al. (2008). Pyrosequencing analysis of the oral microflora of healthy
adults. J. Dent. Res. 87, 1016–1020. doi: 10.1177/154405910808701104
Konstantinidis, K. T., and Tiedje, J. M. (2007). Prokaryotic taxonomy and
phylogeny in the genomic era: advancements and challenges ahead. Curr. Opin.
Microbiol. 10, 504–509. doi: 10.1016/j.mib.2007.08.006
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud,
M., et al. (2013). Fusobacterium nucleatum potentiates intestinal tumorigenesis
and modulates the tumor-immune microenvironment. Cell Host Microbe. 14,
207–215. doi: 10.1016/j.chom.2013.07.007
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., et al.
(2012). Genomic analysis identifies association of fusobacteriumwith colorectal
carcinoma. Genome Res. 22, 292–298. doi: 10.1101/gr.126573.111
Lazarevic, V., Whiteson, K., Huse, S., Hernandez, D., Farinelli, L., Osteras,
M., et al. (2009). Metagenomic study of the oral microbiota by
Illumina high-throughput sequencing. J. Microbiol. Methods 79, 266–271.
doi: 10.1016/j.mimet.2009.09.012
Lin, L., and Zhang, J. (2017). Role of intestinal microbiota and metabolites
on gut homeostasis and human diseases. BMC Immunol. 18:2.
doi: 10.1186/s12865-016-0187-3
Luo, J. L., Maeda, S., Hsu, L. C., Yagita, H., and Karin, M. (2004). Inhibition of NF-
kappaB in cancer cells converts inflammation- induced tumor growthmediated
by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 6, 297–305.
doi: 10.1016/j.ccr.2004.08.012
Lupton, J. R. (2004). Microbial degradation products influence colon cancer risk:
the butyrate controversy. J. Nutr. 134, 479–482.
Mantovani, A. (2009). Cancer: inflaming metastasis. Nature 457, 36–37.
doi: 10.1038/457036b
Martin, O. C. B., Lin, C., Naud, N., Tache, S., Raymond-Letron, I., Corpet, D. E.,
et al. (2015). Antibiotic suppression of intestinal microbiota reduces heme-
induced lipoperoxidation associated with colon carcinogenesis in rats. Nutr.
Cancer 67, 119–125. doi: 10.1080/01635581.2015.976317
McCoy, A. N., Araújo-Pérez, F., Azcárate-Peril, A., Yeh, J. J., Sandler, R. S., and
Keku, T. O. (2013). Fusobacterium is associated with colorectal adenomas. PLoS
ONE 8:e53653. doi: 10.1371/journal.pone.0053653
Morgan, M. J., Bass, D., Bik, H., Birky, C.W., Blaxter, M., Crisp, M. D., et al. (2014).
Noise obscures the genetic signal of meiobiotal ecospecies in ecogenomic
datasets. Proc. Biol. Sci. 281:20133076. doi: 10.1098/rspb.2013.3076
Nasidze, I., Li, J., Quinque, D., Tang, K., and Stoneking, M. (2009). Global
diversity in the human salivary microbiome. Genome Res. 19, 636–643.
doi: 10.1101/gr.084616.108
Frontiers in Microbiology | www.frontiersin.org 12 January 2018 | Volume 8 | Article 2699
Russo et al. Oral and Intestinal Microbiota Characterization
O’Keefe, S. J. (2016). Diet, microorganisms and theirmetabolites, and colon cancer.
Nat. Rev. Gastroenterol. Hepatol. 13, 691–706. doi: 10.1038/nrgastro.2016.165
Oksanen, J., Guillaume Blanchet, F., Kindt, R., Legendre, P., Minchin, P. R.,
O’Hara, R. B., et al. (2015). Vegan: Community Ecology Package. R package
version 2.3-2. 2015. Available online at: https://CRAN.R-project.org/package=
vegan
Parkin, D. M. (2006). The global health burden of infection-associated cancers in
the year 2002. Int. J. Cancer 118, 3030–3044. doi: 10.1002/ijc.21731
Paulson, J. N., Stine, O. C., Bravo, H. C., and Pop, M. (2013). Differential
abundance analysis for microbial marker-gene surveys. Nature Methods 10,
1200–1202. doi: 10.1038/nmeth.2658
Periasamy, S., and Kolenbrander, P. E. (2009). Aggregatibacter
actinomycetemcomitans builds mutualistic biofilm communities with
Fusobacterium nucleatum and Veillonella species in saliva. Infect. Immun. 77,
3542–3551. doi: 10.1128/IAI.00345-09
Pessione, E. (2012). Lactic acid bacteria contribution to gut microbiota
complexity: lights and shadows. Front. Cell Infect. Microbiol. 2:86.
doi: 10.3389/fcimb.2012.00086
Pinheiro, J., Bates, D., DebRoy, S., Sarkar, D., and R Core Team (2016). _nlme:
Linear and Nonlinear Mixed Effects Models_. R package version 3.1-128.
Available online at: http://CRAN.R-project.org/package=nlme
Pruesse, E., Peplies, J., and Glöckner, F. O. (2012). SINA: accurate high-throughput
multiple sequence alignment of ribosomal RNA genes. Bioinformatics 28,
1823–1829. doi: 10.1093/bioinformatics/bts252
Ramos, A., and Hemann, M. T. (2017). Drugs, bugs, and cancer: Fusobacterium
nucleatum promotes chemoresistance in colorectal cancer. Cell 170, 411–413.
doi: 10.1016/j.cell.2017.07.018
R Core Team (2014). R: A Language and Environment for Statistical Computing.
Vienna: R Foundation for Statistical Computing. Available online at: http://
www.R-project.org/
Rowland, I. R. (2009). The role of the gastrointestinal microbiota
in colorectal cancer. Curr. Pharmaceut. Design 15, 1524–1527.
doi: 10.2174/138161209788168191
Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., and Han, Y. W. (2013).
Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating
e-cadherin/β-catenin signaling via its fada adhesin. Cell Host Microbe. 14,
195–206. doi: 10.1016/j.chom.2013.07.012
Russo, E., Taddei, A., Ringressi, M. N., Ricci, F., and Amedei, A. (2016).
The interplay between the microbiome and the adaptive immune
response in cancer development. Ther. Adv. Gastroenterol. 9, 594–605.
doi: 10.1177/1756283X16635082
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S.,
et al. (2011). Metagenomic biomarker discovery and explanation. Genome Biol.
12:R60. doi: 10.1186/gb-2011-12-6-r60
Tremaroli, V., and Bäckhed, F. (2012). Functional interactions between
the gut microbiota and host metabolism. Nature 489, 242–249.
doi: 10.1038/nature11552
Warren, R. L., Freeman, D. J., Pleasance, S., Watson, P., Moore, R. A., Cochrane,
K., et al. (2013). Co-occurrence of anaerobic bacteria in colorectal carcinomas.
Microbiome 1:16. doi: 10.1186/2049-2618-1-16
Wesolowska-Andersen, A., Bahl, M. I., Carvalho, V., Kristiansen, K., Sicheritz-
Pontén, T., Gupta, R., et al. (2014). Choice of bacterial DNA extraction
method from fecal material influences community structure as evaluated by
metagenomic analysis.Microbiome 2:19. doi: 10.1186/2049-2618-2-19
West, B. T., Welch, K. B., and Galecki, A. T. (2014). Linear Mixed Models: A
Practical Guide Using Statistical Software. Boca Raton, FL: CRC Press.
Wickham, H. (2009). ggplot2: Elegant Graphics for Data Analysis. New York, NY:
Springer-Verlag.
Williams, S. T., and Beart, R. W. (1992). Staging of colorectal cancer. Semin. Surg.
Oncol. 8, 89–93.
Yang, J., and Weinberg, R. A. (2008). Epithelial-mesenchymal transition: at the
crossroads of development and tumor metastasis. Dev. Cell 14, 818–829.
doi: 10.1016/j.devcel.2008.05.009
Zhang, S., Cao, X., and Huangm, H. (2017). Sampling strategies for three-
dimensional spatial community structures in IBD microbiota research. Front.
Cell. Infect.Microbiol. 7:51. doi: 10.3389/fcimb.2017.00051
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 Russo, Bacci, Chiellini, Fagorzi, Niccolai, Taddei, Ricci, Ringressi,
Borrelli, Melli, Miloeva, Bechi, Mengoni, Fani and Amedei. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 13 January 2018 | Volume 8 | Article 2699
